Screener
Novavax NVAX Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Novavax’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Product sales | $18,854 | $10,724 | $61,054 | $632,402 |
| Licensing, royalties, and other | 37,844 | 228,516 | 135,158 | 273,493 |
| Total revenue | 56,698 | 239,240 | 196,212 | 905,895 |
| Expenses: | ||||
| Cost of sales | 14,246 | 15,325 | 44,941 | 29,439 |
| Research and development | 70,693 | 79,233 | 166,165 | 168,170 |
| Selling, general, and administrative | 26,665 | 43,612 | 55,442 | 91,702 |
Item 1. Consolidated Financial Statements
FAQ
- What is Novavax's total revenue?
- Novavax (NVAX) reported total revenue of $56.7M in Q2 2026.
- How has Novavax's total revenue changed year-over-year?
- Novavax's total revenue decreased by 76.3% year-over-year, from $239.24M to $56.7M.
- What is the long-term trend for Novavax's total revenue?
- Over 4 years (2021 to 2025), Novavax's total revenue has grown at a -0.5% compound annual growth rate (CAGR), from $1.15B to $1.12B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Novavax's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude